Ondine Biomedical

Ondine Biomedical Inc., headquartered in Vancouver, Canada, is a biotechnology company specializing in the development and commercialization of non-antibiotic therapies for bacterial, viral, and fungal infections through its innovative Photodisinfection technology. This light-activated technology offers antimicrobial efficacy while mitigating the risks associated with antibiotic resistance. Ondine's key products include Periowave, an adjunctive therapy for chronic adult periodontitis, and the MRSAid Photodisinfection system, which targets methicillin-resistant Staphylococcus aureus. Additional offerings include Endowave, designed to eliminate bacterial biofilms in endotracheal tubes, and Vitalwave, aimed at decolonizing the birth canal to prevent the transmission of pathogens such as HIV. The company also collaborates with Sinuwave Technologies Corporation to develop treatments for chronic sinusitis. Ondine Biomedical was formerly known as Ondine Biopharma Corporation until its name change in October 2010.